Click photo to enlarge

Brittany Burgo after she was named overall high-school-aged Youth of the Year by the Boys & Girls Clubs of North San Mateo County on Jan. 24, 2013 at the Basque Cultural Center in South San Francisco.

JobTrain, Employment Development Department, and Workforce Development San Mateo County are sponsoring a Job and Networking Fair from 10 a.m. to 2 p.m. Wednesday at the Silicon Valley Foundation Center, 1300 S. El Camino Real, Suite 100, in San Mateo.

While open to all job seekers, priority will be given to veterans. Auxiliary aids and services are available upon request for those with disabilities.

Participating employers include: AccentCare; Arbonne International; Bauer's Transportation; California Conservation Corps; Customs & Border Protection; Delta Dental; FBI; Goodwill Industries; Jem Restaurant Management; JP Morgan Chase; Reliable Caregivers; Solar City; and more.

For details, call Jasmine Baluyot at 650-330-6430 or Johnnie Stanton at 415-749-7534. For future event dates, visit http://www.jobtrainworks.org.

'Surfing for Life' documentary to be aired in Pacifica

The Pacifica Beach Coalition is presenting "Surfing for Life," an award-winning documentary by David L. Brown and Roy Earnest, at 6 p.m. and also at 8:30 p.m. Feb. 22 at the Mildred Owen Concert Hall, 1220 Linda Mar Blvd., in Pacifica.

Sponsored by Recology of the Coast and Pacifica's Environmental Family, the two showings are a benefit screening for the Coalition's Earth Day Event on April 20. A mini-segment from Powerlines Production's "Super Natural," featuring big

No host wine and beer and raffle prizes will be available.

Follow this link:
Carolyn Livengood: Job and Networking Fair to be held in San Mateo

BURBANK, Calif., Feb. 15, 2013 /PRNewswire-USNewswire/ -- Woodbury University today announced the appointment of Shari Bowles Gibbons as chief marketing officer, effective April 1.

Gibbons will lead and advance the branding, marketing, and communication strategy and programs of the university. She brings to Woodbury extensive brand-building experience with start-ups and brand repositioning experience with global brand leaders. Gibbons is currently serving as the chief operating officer of Battery-Biz, a leading distributor of power accessories for consumer electronic devices. She previously held executive positions at Kaplan Medical Licensing, Front Row Films, and Warner Brothers Entertainment, Inc.

"Shari brings to Woodbury as passion for building high-performance teams. Her commitment to education and lifelong learning has been demonstrated through her volunteer work as board member and past president of the Harvard Business School Alumni Association of Southern California (HBSASC)," says Luis Ma. R. Calingo, Ph.D., president, Woodbury University.

Gibbons earned an MBA from Harvard Business School and a bachelor of arts from San Jose State University.

Founded in 1884, Woodbury University is one of the oldest institutions of higher education in Southern California. Woodbury offers bachelor's degrees from the School of Architecture, School of Business, School of Media, Culture & Design, and Institute of Transdisciplinary Studies, along with an MBA program, Master of Architecture (MArch), Master of Science in Architecture (MSArch), and Master of Organizational Leadership. A San Diego campus offers bachelor of architecture, Master of Real Estate Development for Architects (MRED), and Master of Science in Architecture, Landscape, and Urbanism degrees.

SOURCE Woodbury University

Read more from the original source:
Woodbury University Appoints Shari Bowles Gibbons as CMO

This week was Valentines Day and this is a love story. Two medical students met and fell in love at the historically black Meharry Medical College. Sixty-five years later, as a couple they are expressing their feelings for their school by allowing Meharrys National Alumni Association, Miami Chapter, to honor them by raising funds to contribute to the schools endowment insuring training for future generations of medical doctors. The dinner gala, A Celebration of Legacy Honoring Dr. George A. and Dr. Dazelle Dean Simpson, will be held April 19 at the Hyatt Regency Miami, 400 SE Second Ave., Miami. For ticket and donation information visit meharrymiami.org or call 305.705-3516.

During a recent telephone interview, the doctors Simpson finished each others sentences while speaking about their life together and their love for Meharry Medical College. George Simpson first noticed Dazelle Dean during his first year in medical school because of the high grades she was making.

As a New Yorker I was surprised to hear that someone from the south was making higher grades than me, he said. It was a rude awakening when I discovered it was someone from Miami consistently scoring high on the tests. Eventually we started studying and developing projects together and became friends.

He recalls that they did not date for the first time until junior year. She was surprised one day in the lecture hall stairwell when he abruptly said, I am going to marry you. Although he did not get down on one knee as she expected, she did not hesitate to say yes. He said he was to poor too buy her an engagement ring at that time. They married during their final year in medical school. It was a traditional family wedding on Dec. 26, 1949, at Christ Episcopal Church in Coconut Grove. The Rev. Theodore R. Gibson officiated. A native Miamian, the bride is the granddaughter of Coconut Grove real estate pioneer E.W.F. Stirrup.

Doctors George and Dazelle Simpson graduated from Meharry Medical College in 1950. That summer, Dr. George accepted an Externship in Fort Lauderdale with pioneer black physician Dr. James Sistrunk. During the next eight years, he was a surgical intern and resident and later completed two years of military service as a first lieutenant at Fort Dix Army Hospital.

Dr. Dazelles commitment to children led her to pursue a specialty in pediatrics. After a residency in pediatrics at Hubbard Hospital of Meharry Medical College, she returned to Miami where she practiced for 42 years (1953-1995). In 1958, he joined his wife in Miami and established his private practice in General Surgery (1958 -1990). To their union were born 3 children, 2 grandchildren and 5 great grandchildren.

As each continued in private practice, their love of medicine grew to include the Miami-Dade County community. Dr. Dazelle Simpsons accomplishments include: first board certified black pediatrician in Florida; first woman and first black member of the University of Miami School of Medicine Admissions Committee; first black president, Greater Miami Pediatric Society; president of Florida Medical, Dental, and Pharmaceutical Association; vice chairman, Board of Directors, Miami Childrens Hospital; chairman, Pediatric Section, National Medical Association; senior attending physician, Department of Pediatrics; and Board Member, Family Christian Association of America.

Dr. George Simpson was the first black board certified general surgeon in Florida; the first black doctor on teaching staff in General Surgery at Jackson Memorial Hospital; a founding member, Jackson Memorial SEIU; medical director and later Chairman of the Board, Economic Opportunity Family Health Center (the primary training ground for family medicine in Miami-Dade County); chairman of the board of Christian Hospital; and an original member, Dade County Community Relations Board.

In addition to their family, practices and community organizations both were passionate about assuming leadership roles in local, state and national organizations to train future black doctors.

Dr. James Bridges, Miami Chapter president of Meharry Medical Colleges alumni association says this is the opportunity for the hundreds of students, patients and co-workers touched by these two medical trailblazers to show appreciation now for the Simpsons to enjoy as they live happily ever after in retirement.

Read the original post:
Med school to honor pioneering black doctors

I have a confession to make. My parents are paying for every cent of my college education: $220,000 or more over four years. I am supremely in their debt.

Sadly, I have no concept of what it truly represents. You could call me spoiled or ungrateful and I admit sometimes I am both of those. In this case, its similar to how, as Americans, we look at our $16.4 trillion deficit or at our 601 percent increase in medical spending over the last 30 years. We cringe and keep walking or spending. In fact, there is a lot that we can learn from the parallel ascent of tuitions and medical costs.

There are several problems with how we practice medicine. Part of the problem with medical care is that many consumers are too removed from the actual costs. Most people likely dont know that it can cost anywhere from $10,000 to $32,000 to give birth to a baby. People are generally given the bill for their medical care upon treatment, when it is too late to refuse or search for cheaper options.

Normally, competition and consumer choice lead to greater efficiency and better value for the consumer. Still, if consumers dont know the products true costs, then price competition cannot exist. With medical care, there is no direct incentive for consumers to push for more efficiency their insurers will cover it. Our hospital incentive system is also terrible. Doctors are commonly compensated for how many procedures and tests they prescribe and not based on successful outcomes or efficiency. The incentives say more is better, no matter what. The result of opaque costs and backward incentives is that we pay 250 percent more per person per year than does the average developed nation and we still have a lower life expectancy.

Our system of higher education suffers from the same fundamental issues. During the application process it is definitely easy to figure out the cost of tuition, but what about room and board, textbooks and transportation? And where does that $50,000 or more actually go? Does it fund things directly related to your concentration? Or does it go to obscure sports teams, random school conferences and lawn maintenance?

Isnt our education about getting an education and not all the random country-club frills our school can throw at us? Just like in medical care, the majority of consumers have no real incentive to push for efficiency and greater value. Upper-class students receive family funding. Lower- and middle-class students receive need-blind financial aid, apply for scholarships or are saddled with debt. Any individual in my generation who would be sufficiently worried about the college process to start a movement against tuition hikes generally decides that a better use of time would be to apply for a couple of extra scholarships or student loans. On campus, the only sustained movement to help with the student tuition burden is fighting for financial aid, but wouldnt it help more people to fight the tuition increases alone? Our apathy, or in some cases our misdirected action, is bleeding us dry.

Our rankings-obsessed incentive system does not help the matter either. The most influential college ranking system is the U.S News and World Reports annual list. According to an article by U.S News and World Report on its ranking methodology, academic quality factors such as faculty resources financial resources (and) alumni giving account for 35 percent of a schools score. There is no mention of a tuition cost-benefit valuation or any sort of efficiency rating. The ratings suggest that the more a school pays for random crap, the better the school. Weve seen how well that idea works in public education. This system stirs a veritable tuition arms race for any school, like Brown, that wants to stay near the top of the rankings, and it results in the nations massive long-term climb in tuition. If the current trend of an average annual price increase of 4.4 percent at Brown continues, then a Brown education will cost over $70,000 per year by 2026. Hurray.

So what solutions do we have? I have two simple ideas that would at least help slow the increase in costs for both industries: Inform the consumer and change the industry incentives.

Multiple studies have shown that the more informed people are about their finances, the less they spend. The government should mandate that both industries reveal costs and future costs upfront. A good model would be like the information cards car dealerships display about gas consumption, smog ratings and ownership costs. If there were a measly 1 percent annual reduction in tuition or health care due to this mandate, it would still be a massive change.

Changing industry incentives would be much more difficult. The health care battles would, once again, be huge. There would have to be some sort of popular movement against current college ranking ideology. When either system becomes too broken, the public will come to the conclusion that these institutions must change their incentives and, ideally, there will be an improved system.

Go here to see the original:
Enriquez ’16: Let’s throw money at it

COLORADO SPRINGS, Colo., Feb. 12, 2013 /PRNewswire/ --Cannabis Science, Inc. (NASDAQ OTC: CBIS) has appointed Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics, and Oncology with secondary appointments as Professor in the Department of Genetics and Pathology and a Member of the Center for RNA Biology at the University of Rochester, School of Dentistry and Medicine, to the Company's Scientific Advisory Board. At the University of Rochester Dr. Smith directs a research laboratory and teaches undergraduate and medical school courses in biochemistry. He is a member of the RNA Society and a member of the American Association for the Advancement of Science. He received the SUNY at Buffalo's Distinguished Alumni Award as well as several awards from the University or Rochester for contributions to the teaching mission and leadership in mentoring. Dr. Smith has been an opinion leader in RNA biology where he established the first Gordon Research conference on RNA Editing. Dr. Smith has also been the recipient of a number of grants, including grants from the Bill and Melinda Gates Foundation, the NIH, the United States Air Force, and the Office of Naval Research. In total, Dr. Smith has received federal and foundation research grants in excess of $6.5 million. Dr. Smith has been an opinion leader in RNA biology where he established the first Gordon Research conference on RNA Editing. Dr. Smith is the author of more than 100 peer-reviewed manuscripts and reviews during his career, exceeding more than 9,973 citations.

Dr. Smith received his Ph.D. from SUNY at Buffalo, following BS and MS degrees from Purdue University and an MA degree from SUNY at Buffalo. Dr. Smith also held post-doctoral positions in biochemistry at SUNY at Buffalo followed by three post-doctoral positions in biochemistry, pharmacology, and medical genetics, respectively, at Baylor College of Medicine.

In addition, Dr. Smith is the Founder and CEO of OyaGen, Inc., a biotech company in Rochester, New York developing novel therapeutics for infectious disease and cancer. OyaGen has raised in excess of $4 million from venture and angel investor sources and two federal grants for assay development.

Dr. Smith stated, "It is my pleasure to join the scientific advisory board of CBIS. In joining the Company's SAB, I hope to bring over 30 years of research experience in cancer and HIV to assist in developing a clear platform for the commercialization of CS-TATI-1 and CS-S/BCC-1. I look forward to assisting in the realization of bridging macro and microbiology in discovering new applications for the medicinalization of cannabinoids."

"We are honored to have Dr. Smith join the Scientific Advisory Board of Cannabis Science. Dr. Smith's broad experience in multidisciplinary biological research and professional development of therapeutics consistent with the goals of the Company make him a tremendously valuable addition to the Cannabis Science team, as we move forward in drug development," stated Robert Melamede, Ph.D., President and CEO of Cannabis Science.

About CS-TATI-1Cannabis Science's research of CS-TATI-1 will be targeted to newly diagnosed patients infected with drug resistant virus, treatment experienced patients with drug-resistant HIV strains, and those intolerant of currently available therapies. Cannabis Science will be pursuing a wide range of NIH based Federal Research Programs such as RO1's, PO1's and SBIRS which exist to support preclinical development of target validation and proof of concept studies. These studies will be implemented through collaborations with leading scientific institutions. Cannabis Science will also be pursuing other clinical research collaborations including the AIDS Clinical Trials Groups (ACTG), the Canadian AIDS Trial Network (CATN) and the European AIDS Trial Network (EATN).

About CS-S/BCC-1Cannabis Science is currently working to develop preclinical investigations of CS-S/BCC-1 treatment of basal and squamous cell carcinomas. The Company has begun preclinical investigations, which are being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.

About Cannabis Science, Inc.Cannabis Science, Inc. is at the forefront of cannabinoid research and development for unmet medical needs. The Company works with leading experts in HIV drug development, medicinal characterization, and clinical research to develop, produce, and commercialize Phytocannabinoid-based pharmaceutical products.

Forward Looking StatementsThis Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," "intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contact:

Follow this link:
Cannabis Science, Inc. Appoints Harold C. Smith, Ph.D., Professor in Biochemistry, Biophysics and Oncology and a ...

Interview by John A. Byrne

(Poets&Quants) -- If Columbia Business School Dean Glenn Hubbard were to advise his McKinsey-bound son on where to get his MBA, Hubbard says there are only four or five programs that he would recommend. He declines to mention the schools by name, but you can rest assured that Columbia would be on the list along with Harvard, Stanford, and Wharton. That leaves a lot of very good schools off the list.

Hubbard, dean of Columbia's business school since July 2004, is an economist by training. He joined Columbia in 1988, after beginning his teaching career at Northwestern. He was chairman of the Council of Economic Advisers under President George Bush and a top economic advisor to Mitt Romney during his recent presidential campaign.

In a wide-ranging interview with Poets&Quants, Hubbard discusses, among other things, the anxiety in MBA programs, whether Warren Buffett will become a donor, and Columbia's MBA application plunge last year, vastly exceeding downturns at other elite business schools.

Last year, applications to Columbia's MBA program fell by 19%, more than at any other top business school. How are things looking this year?

We are fortunate that our applications are up 9% year-over-year. What was weird about our drop is that it came along all at once. I told the faculty I felt like Wile E. Coyote, where he ran off the cliff and didn't know it yet. We had a couple of years where applications had plateaued and then all of a sudden crashed. But fortunately we are back up.

Your decline was generally attributed to Wall Street's troubles and the fact that Columbia's fortunes are so closely tied to Wall Street. Agree?

Wharton had a similar pattern. And if you were to do a trend line, we are both on that line. Harvard is above it. Harvard is the one school at the top where if you did a trend line pre-crisis and looked at applications, it's above it.

Do you think the decline is related to the belief that the value of the MBA degree has declined?

No. I think the value of the degree is still very high if you can go to a good school. If you go to any top business school, you will gain a skill set and mindset to make you a very good business leader. If you have in mind only an analytical job track, you might want to question the ROI. I think it's really hard to defend, at least in money terms, the value of an MBA beyond the top business schools.

See the original post:
Is an MBA worth it?